RNGE
PINK Range Impact Inc$0.6400 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.6400, $0.0191 below the day’s high of $0.6591
- YTD change
- +321.05%
- vs 20-day SMA
- -11.54%
- vs 200-day SMA
- +55.09%
Price ranges
Price & Performance
+0.45 (+228.21%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 35.4% away from all-time highs of $0.9900
- RNGE is up 321% since the beginning of the year
- RNGE is up 237% over the past 12 months
- RNGE is down 19% over the past 1 month
RNGE reads neutral: price sits above one of the two key moving averages, the 12-month move is +220.0%.
- Previous minute
- +$0.0000
- Last hour
- +$0.0023
- Last 5 days
- -6.54%
- vs 8-day SMA
- -3.92%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Range Impact, Inc. engages in unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders. It operates through Pharmaceutical Operations and Clinical Operations segments. The Clinical Operations segment focuses on treating patients suffering from addiction and dependency. The Pharmaceutical Operations segment engages in research and development primarily related to the Company’s cannabinoid pharmaceuticals. The company was founded by Avtar S. Dhillon and Robert T. Brooke on June 29, 2007 and is headquartered in Cleveland, OH.
Competitor comparison
No peer group available for this symbol.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.